Clinical and Life Sciences · 1 October 2026 to 1 October 2026 · 1 headlines · MedPage Today
'Lean' MASLD May Sound Better, but Study Suggests Otherwise
A new study suggests that despite its name, "lean" MASLD (metabolic dysfunction-associated steatotic liver disease) may not actually carry a more favorable outlook than other forms of the condition.
As it ran
1 October 2026
More from US healthcare
- Medicare Advantage looks stable for 2027. Underneath, it’s shifting 1 October 2026
- I studied GLP-1 use in children. The results are reassuring 1 October 2026
- UniQure's Huntington's gene therapy trial 1 October 2026
- Data privacy concerns could hold patients back from using AI 1 October 2026
- Epic Fail: Robots Don't Improve Joint Replacement Outcomes in Big U.K. Studies 1 October 2026
- Merck discontinues antibiotic Recarbrio in US 1 October 2026
- Millions of Cancers Linked to Infections, Study Says 1 October 2026
- New Easier-to-Use GLP-1 Pill Safe for the Heart, Study Says 1 October 2026